Wilmington Trust Investment Management’s Boston Scientific BSX Stock Holding History

Wilmington Trust Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$183K	Sell	14,360 -5,000	-26%	-$65K	0.04%	368
2014 Q1	$262K	Sell	19,360 -10,000	-34%	-$131K	0.05%	298
2013 Q4	$353K	Sell	29,360 -5,700	-16%	-$67.3K	0.07%	240
2013 Q3	$412K	Hold	35,060	–	–	0.09%	204
2013 Q2	$325K	Buy	+35,060	New	+$297K	0.07%	264

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wilmington Trust Investment Management's BSX Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Boston Scientific (BSX) stake by 26% in Q2 2014, selling an estimated $65K and leaving 14,360 shares worth $183K. The position accounts for 0.04% of the portfolio, ranked #368.

Wilmington Trust Investment Management first reported a position in BSX in Q2 2013 and has held it in 5 quarters since. The position peaked at $412K in Q3 2013. 458 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

Wilmington Trust Investment Management held 14,360 shares of Boston Scientific worth $183K as of Q2 2014.
Wilmington Trust Investment Management sold 5,000 Boston Scientific shares in Q2 2014, an estimated $65K.
Boston Scientific made up 0.04% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #368 holding.
Wilmington Trust Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust Investment Management's Boston Scientific position peaked at $412K in Q3 2013.
458 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.